Recommended in Urology

Testosterone treatment in older men increase coronary artery plaque volume
  • JAMA
  • 1 comment
  • FULLTEXT

Testosterone treatment in older men increase coronary artery plaque volume

The Cardiovascular Trial design to determine the effect of testosterone treatment on cardiovascular outcome in older men with low testosterone concentrations

Read more
  • Clinical Essentials from JAMA Oncol
  • 1 comment

Prostate cancer: can this biomarker predict response to ADT?

Read more
  • Clinical Essentials from J Urol
  • 1 comment

Refractory IC/BPS: intravesical lipotoxin fails to show benefit

Read more
  • Clinical Essentials from Eur Urol
  • 1 comment

Aspirin may reduce risk for lethal prostate cancer

Read more
  • Clinical Essentials from BJU Int
  • 1 comment

Prostate cancer: mpMRI improves detection of significant cancer by 9%

Read more
  • Vitals
  • 1 comment

Primary Care Oncology Vitals for February 2017

Read more
  • Clinical Essentials from BJU Int
  • 1 comment

Prostate cancer: consensus on sentinel node biopsy

Read more
  • Clinical Essentials from J Hosp Infect
  • 1 comment

Infection site, urinary catheter insertion prognostic for severe sepsis

Read more
  • Clinical Essentials from FDA
  • 1 comment

FDA approves nivolumab for urothelial carcinoma

Read more

Professional Essentials

  • US Professional News

More physicians are getting MBAs to cope with health system changes

Read more
  • US Professional News

Physicians continue to offer outdated treatments, article concludes

Read more
  • US Professional News

CMS randomized study of payment program could deter physicians

Read more
  • US Professional News

Should physicians have beards? Gravitas vs hygiene

Read more
  • Patients Will Be Asking

Is testosterone right for me?

Read more
  • Patients Will Be Asking

Could my excessive and circuitous speech be a sign of declining cognition?

Read more
View more

New in Urology

  • Clinical Essentials from J Clin Oncol
  • 1 comment

Renal cancer: cabozantinib tops sunitinib as first-line treatment

Preliminary data show a 20% decrease in the rate of death with cabozantinib compared with sunitinib.

Read more
  • Clinical Essentials from Clin Cancer Res
  • 1 comment

MRCC: sunitinib-related cardiotoxicity is largely reversible

Is routine monitoring needed for asymptomatic patients?

Read more
  • The ASCO Post
  • 1 comment

2017 GU Cancers Symposium: Blood Test Uncovers Potential New Treatment Targets in Advanced Prostate Cancer

<p>Using a &ldquo;liquid biopsy&rdquo; test in patients with advanced prostate cancer, researchers found a number of genetic changes in cell-free, circulating tumor DNA.</p>

Read more
  • The ASCO Post
  • 1 comment

2017 GU Cancers Symposium: Some Patients With Renal Cell Carcinoma Experience Long-Term Tumor Control Even After Stopping Immunotherapy Early

<p>Among patients with advanced kidney cancer who stopped immune checkpoint inhibitor therapy early due to side effects, 42% had a durable response.</p>

Read more
  • The ASCO Post
  • 1 comment

2017 GU Cancers Symposium: In Advanced Kidney Cancer, Antibiotic Use Lowers Efficacy of Immunotherapy

<p>Immunotherapy may be less effective in patients with advanced kidney cancer who receive antibiotics less than a month before starting treatment.</p>

Read more
  • Clinical Essentials from Otolaryngol Head Neck Surg
  • 1 comment

In sleep surgery for OSA, complications likelier in the elderly

The overall complication rate is still low, so surgery is not contraindicated.

Read more
  • Clinical Essentials from Ann Hematol
  • 1 comment

Lymphoma survivors: sexual dysfunction is common, but differs by sex

Findings may inform the development of sex-specific interventions.

Read more
  • Clinical Essentials from Urol Oncol
  • 1 comment

Bladder cancer: statins fail to improve cancer-specific survival

This is the only population-based study of statins as chemopreventive agents in NMIBC.

Read more
  • Clinical Essentials from Eur Urol
  • 1 comment

Prostate cancer: immediate vs salvage radiotherapy, which is best?

Immediate RT after RP, or salvage RT at the first sign of recurrence – what does the evidence say?

Read more
  • Clinical Essentials from Eur Radiol
  • 1 comment

Bladder cancer: is mpMRI set to become the staging tool of choice?

A trial is underway to determine if transurethral resection can be avoided when mpMRI findings suggest muscle invasion.

Read more
  • Clinical Essentials from Sex Transm Dis
  • 1 comment

One in 4 porn stars has chlamydia or gonorrhea

Adult film performers are at significant risk of acquiring and transmitting STIs.

Read more
  • Clinical Essentials from Urol Oncol
  • 1 comment

Prostate cancer: time to PSA nadir predicts progression with abiraterone, but not enzalutamide

Time to PSA nadir independently predicts PSA-PFS in patients with mCRPC treated with abiraterone acetate.

Read more
  • Clinical Essentials from JAMA Oncol
  • 1 comment

Painful bone metastases: benefits of radiotherapy seen within 10 d

Radiotherapy should be offered to all patients with painful bone metastases, even those with limited life expectancy.

Read more
  • Clinical Essentials from Urology
  • 1 comment

Bladder cancer: robotic, open radical cystemectomy yield similar outcomes

Except for blood transfusion rates, robotic radical cystectomy showed no advantage over the open technique.

Read more